{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:35:57Z","timestamp":1789266957073,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"BlueGenes Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41591-021-01664-4","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T12:02:31Z","timestamp":1644494551000},"page":"251-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["AAV gene therapy for Tay-Sachs disease"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-0588","authenticated-orcid":false,"given":"Terence R.","family":"Flotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Cataltepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"McKenna-Yasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Douthwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1268-7001","authenticated-orcid":false,"given":"Gwladys","family":"Gernoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-8344","authenticated-orcid":false,"given":"Phillip W. L.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-7294","authenticated-orcid":false,"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiro G.","family":"Spanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Parzych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-4616","authenticated-orcid":false,"given":"Allison M.","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Abayazeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Rohatgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Finberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-9524","authenticated-orcid":false,"given":"Zeynep","family":"Vardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Salman","family":"Shazeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8034-2785","authenticated-orcid":false,"given":"Matthew","family":"Gounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian S.","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6062-1528","authenticated-orcid":false,"suffix":"Jr.","given":"Robert H.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3444-8407","authenticated-orcid":false,"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-0143","authenticated-orcid":false,"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"1664_CR1","doi-asserted-by":"publisher","first-page":"e1233","DOI":"10.1542\/peds.2011-0078","volume":"128","author":"AE Bley","year":"2011","unstructured":"Bley, A. E. et al. Natural history of infantile G(M2) gangliosidosis. Pediatrics 128, e1233\u2013e1241 (2011).","journal-title":"Pediatrics"},{"key":"1664_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1664_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/mt.2010.135","volume":"18","author":"S Muramatsu","year":"2010","unstructured":"Muramatsu, S. et al. A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson\u2019s disease. Mol. Ther. 18, 1731\u20131735 (2010).","journal-title":"Mol. Ther."},{"key":"1664_CR4","doi-asserted-by":"publisher","first-page":"134ra161","DOI":"10.1126\/scitranslmed.3003640","volume":"4","author":"WL Hwu","year":"2012","unstructured":"Hwu, W. L. et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency. Sci. Transl. Med. 4, 134ra161 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1664_CR5","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.1128\/JVI.77.12.7034-7040.2003","volume":"77","author":"MA Passini","year":"2003","unstructured":"Passini, M. A. et al. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice. J. Virol. 77, 7034\u20137040 (2003).","journal-title":"J. Virol."},{"key":"1664_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/gt.2012.101","volume":"20","author":"SJ Gray","year":"2013","unstructured":"Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J. & Jude Samulski, R. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther. 20, 450\u2013459 (2013).","journal-title":"Gene Ther."},{"key":"1664_CR7","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/hum.2013.005","volume":"24","author":"L Samaranch","year":"2013","unstructured":"Samaranch, L. et al. Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum. Gene Ther. 24, 526\u2013532 (2013).","journal-title":"Hum. Gene Ther."},{"key":"1664_CR8","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/mt.2014.135","volume":"22","author":"C Hinderer","year":"2014","unstructured":"Hinderer, C. et al. Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I. Mol. Ther. 22, 2018\u20132027 (2014).","journal-title":"Mol. Ther."},{"key":"1664_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer, K. et al. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates. Mol. Ther. 23, 477\u2013487 (2015).","journal-title":"Mol. Ther."},{"key":"1664_CR10","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1038\/mtm.2016.46","volume":"3","author":"A Miyanohara","year":"2016","unstructured":"Miyanohara, A. et al. Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs. Mol. Ther. Methods Clin. Dev. 3, 16046 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1664_CR11","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/mt.2008.166","volume":"16","author":"CN Cearley","year":"2008","unstructured":"Cearley, C. N. et al. Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol. Ther. 16, 1710\u20131718 (2008).","journal-title":"Mol. Ther."},{"key":"1664_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/gt.2012.27","volume":"20","author":"EA Salegio","year":"2013","unstructured":"Salegio, E. A. et al. Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther. 20, 348\u2013352 (2013).","journal-title":"Gene Ther."},{"key":"1664_CR13","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1523\/JNEUROSCI.22-15-06437.2002","volume":"22","author":"MA Passini","year":"2002","unstructured":"Passini, M. A., Lee, E. B., Heuer, G. G. & Wolfe, J. H. Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream. J. Neurosci. 22, 6437\u20136446 (2002).","journal-title":"J. Neurosci."},{"key":"1664_CR14","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1073\/pnas.0810682106","volume":"106","author":"AP Kells","year":"2009","unstructured":"Kells, A. P. et al. Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc. Natl Acad. Sci. USA 106, 2407\u20132411 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1664_CR15","doi-asserted-by":"publisher","first-page":"e13468","DOI":"10.1371\/journal.pone.0013468","volume":"5","author":"RC Baek","year":"2010","unstructured":"Baek, R. C. et al. AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival. PLoS One 5, e13468 (2010).","journal-title":"PLoS One"},{"key":"1664_CR16","doi-asserted-by":"publisher","first-page":"9928","DOI":"10.1523\/JNEUROSCI.2185-07.2007","volume":"27","author":"CN Cearley","year":"2007","unstructured":"Cearley, C. N. & Wolfe, J. H. A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. J. Neurosci. 27, 9928\u20139940 (2007).","journal-title":"J. Neurosci."},{"key":"1664_CR17","doi-asserted-by":"publisher","first-page":"17822","DOI":"10.1073\/pnas.0509062102","volume":"102","author":"JC Dodge","year":"2005","unstructured":"Dodge, J. C. et al. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease. Proc. Natl Acad. Sci. USA 102, 17822\u201317827 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1664_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/hum.2007.104","volume":"19","author":"KD Foust","year":"2008","unstructured":"Foust, K. D., Flotte, T. R., Reier, P. J. & Mandel, R. J. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat. Hum. Gene Ther. 19, 71\u201382 (2008).","journal-title":"Hum. Gene Ther."},{"key":"1664_CR19","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.1073\/pnas.0603765103","volume":"103","author":"MB Cachon-Gonzalez","year":"2006","unstructured":"Cachon-Gonzalez, M. B. et al. Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc. Natl Acad. Sci. USA 103, 10373\u201310378 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1664_CR20","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/mt.2012.44","volume":"20","author":"MB Cachon-Gonzalez","year":"2012","unstructured":"Cachon-Gonzalez, M. B. et al. Gene transfer corrects acute GM2 gangliosidosis\u2013potential therapeutic contribution of perivascular enzyme flow. Mol. Ther. 20, 1489\u20131500 (2012).","journal-title":"Mol. Ther."},{"key":"1664_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/hum.2017.163","volume":"29","author":"H Gray-Edwards","year":"2018","unstructured":"Gray-Edwards, H. et al. AAV gene therapy in a sheep model of Tay-Sachs disease. Hum. Gene Ther. 29, 312\u2013326 (2018).","journal-title":"Hum. Gene Ther."},{"key":"1664_CR22","doi-asserted-by":"publisher","first-page":"175909141556990","DOI":"10.1177\/1759091415569908","volume":"7","author":"HE Rockwell","year":"2015","unstructured":"Rockwell, H. E. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system. ASN Neuro. 7, 1759091415569908 (2015).","journal-title":"ASN Neuro."},{"key":"1664_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","volume":"28","author":"T Taghian","year":"2020","unstructured":"Taghian, T. et al. A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna.Mol. Ther. 28, 411\u2013421 (2020).","journal-title":"Mol. Ther."},{"key":"1664_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0022-3476(64)80161-X","volume":"65","author":"L Schneck","year":"1964","unstructured":"Schneck, L., Maisel, J. & Volk, B. W. The startle response and serum enzyme profile in early detection of Tay-Sachs\u2019 disease. J. Pediatr. 65, 749\u2013756 (1964).","journal-title":"J. Pediatr."},{"key":"1664_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMoa2005056","volume":"383","author":"C Mueller","year":"2020","unstructured":"Mueller, C. et al. SOD1 suppression with adeno-associated virus and microRNA in familial ALS. N. Engl. J. Med. 383, 151\u2013158 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1664_CR26","unstructured":"Singh, A. MRI Atlas of Normal Myelination www.myelinationmriatlas.com (2017)."},{"key":"1664_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.neuroimage.2005.08.017","volume":"29","author":"L Hermoye","year":"2006","unstructured":"Hermoye, L. et al. Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage 29, 493\u2013504 (2006).","journal-title":"Neuroimage"},{"key":"1664_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0925-4439(99)00074-5","volume":"1455","author":"DJ Mahuran","year":"1999","unstructured":"Mahuran, D. J. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim. Biophys. Acta 1455, 105\u2013138 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"1664_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.GIM.0000154300.84107.75","volume":"7","author":"O Neudorfer","year":"2005","unstructured":"Neudorfer, O. et al. Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet. Med. 7, 119\u2013123 (2005).","journal-title":"Genet. Med."},{"key":"1664_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10719-008-9137-5","volume":"26","author":"M Wendeler","year":"2009","unstructured":"Wendeler, M. & Sandhoff, K. Hexosaminidase assays. Glycoconj. J. 26, 945\u2013952 (2009).","journal-title":"Glycoconj. J."},{"key":"1664_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11745-008-3268-0","volume":"44","author":"RC Baek","year":"2009","unstructured":"Baek, R. C., Martin, D. R., Cox, N. R. & Seyfried, T. N. Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease. Lipids 44, 197\u2013205 (2009).","journal-title":"Lipids"},{"key":"1664_CR32","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1074\/jbc.M105457200","volume":"277","author":"ST Hepbildikler","year":"2002","unstructured":"Hepbildikler, S. T., Sandhoff, R., Kolzer, M., Proia, R. L. & Sandhoff, K. Physiological substrates for human lysosomal beta-hexosaminidase S. J. Biol. Chem. 277, 2562\u20132572 (2002).","journal-title":"J. Biol. Chem."},{"key":"1664_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1089\/hum.2016.109","volume":"28","author":"D Golebiowski","year":"2017","unstructured":"Golebiowski, D. et al. Direct intracranial injection of AAVrh8 encoding monkey beta-N-acetylhexosaminidase causes neurotoxicity in the primate brain. Hum. Gene Ther. 28, 510\u2013522 (2017).","journal-title":"Hum. Gene Ther."},{"key":"1664_CR34","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/mt.2013.86","volume":"21","author":"AM Bradbury","year":"2013","unstructured":"Bradbury, A. M. et al. Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy. Mol. Ther. 21, 1306\u20131315 (2013).","journal-title":"Mol. Ther."},{"key":"1664_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/gt.2014.108","volume":"22","author":"VJ McCurdy","year":"2015","unstructured":"McCurdy, V. J. et al. Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease. Gene Ther. 22, 181\u2013189 (2015).","journal-title":"Gene Ther."},{"key":"1664_CR36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/hum.2017.163","volume":"29","author":"HL Gray-Edwards","year":"2018","unstructured":"Gray-Edwards, H. L. et al. Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease. Hum. Gene Ther. 29, 312\u2013326 (2018).","journal-title":"Hum. Gene Ther."},{"key":"1664_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","volume":"28","author":"T Taghian","year":"2020","unstructured":"Taghian, T. et al. A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna. Mol. Ther. 28, 411\u2013421 (2020).","journal-title":"Mol. Ther."},{"key":"1664_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0022-2275(20)39446-3","volume":"13","author":"PD Snyder Jr.","year":"1972","unstructured":"Snyder, P. D. Jr., Krivit, W. & Sweeley, C. C. Generalized accumulation of neutral glycosphingolipids with G M2 ganglioside accumulation in the brain. J. Lipid Res. 13, 128\u2013136 (1972).","journal-title":"J. Lipid Res."},{"key":"1664_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00688589","volume":"66","author":"T Abe","year":"1985","unstructured":"Abe, T., Ogawa, K., Fuziwara, H., Urayama, K. & Nagashima, K. Spinal ganglia and peripheral nerves from a patent with Tay-Sachs disease. Morphological and ganglioside studies. Acta Neuropathol. 66, 239\u2013244 (1985).","journal-title":"Acta Neuropathol."},{"key":"1664_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/archneur.1976.00500020048008","volume":"33","author":"I Rapin","year":"1976","unstructured":"Rapin, I., Suzuki, K. & Valsamis, M. P. Adult (chronic) GM2 gangliosidosis: atypical spinocerebellar degeneration in a Jewish sibship. Arch. Neurol. 33, 120\u2013130 (1976).","journal-title":"Arch. Neurol."},{"key":"1664_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejrad.2018.10.018","volume":"109","author":"R Tutunji","year":"2018","unstructured":"Tutunji, R. et al. Thalamic volume and dimensions on MRI in the pediatric population: normative values and correlations: a cross-sectional study. Eur. J. Radiol. 109, 27\u201332 (2018).","journal-title":"Eur. J. Radiol."},{"key":"1664_CR42","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/hum.2019.288","volume":"31","author":"T Taghian","year":"2020","unstructured":"Taghian, T. et al. Volume and infusion rate dynamics of intraparenchymal central nervous system infusion in a large animal model. Hum. Gene Ther. 31, 617\u2013625 (2020).","journal-title":"Hum. Gene Ther."},{"key":"1664_CR43","doi-asserted-by":"publisher","first-page":"14033","DOI":"10.1038\/mtm.2014.33","volume":"1","author":"M Corti","year":"2014","unstructured":"Corti, M. et al. B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study. Mol. Ther. Methods Clin. Dev. 1, 14033 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1664_CR44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0378-1119(89)90209-6","volume":"79","author":"J Miyazaki","year":"1989","unstructured":"Miyazaki, J. et al. Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 79, 269\u2013277 (1989).","journal-title":"Gene"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01664-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T18:10:58Z","timestamp":1666548658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01664-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1038\/s41591-021-01664-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-195847\/v1","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"31 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Massachusetts Chan Medical School licensed the AAV vectors to Axovant Gene Therapies (now Sio Gene Therapies) in December 2018. Licensing revenue is shared with Auburn University and M.S.-E., D.R.M. and H.G.-E. receive part of the licensing revenue according to institutional policies. The schedule of licensing payments is governed by accomplishment of milestones related to an ongoing phase 1\/2 clinical trial where the investigators named above have no role. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}